Loading...
Isoniazid — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Isoniazid
2025-Q4
Comprehensive analysis of India’s isoniazid export trade — suppliers, buyers, prices, routes, and every shipment record.
86
Shipments
$2.83M
Trade Value
19
Suppliers
38
Buyers
33
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/isoniazid
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s isoniazid trade — 2025-Q4
KEY TAKEAWAY
Isoniazid 2025-Q4 exports total $2.8M across 33 countries, with MACLEODS PHARMACEUTICALS LTD commanding 63.3% market share.
TOTAL SHIPMENTS
86
2025-Q4
EXPORT VALUE
$2.8M
FOB USD
TOTAL QUANTITY
16.5M
units shipped
INDIAN SUPPLIERS
19
unique exporters
GLOBAL BUYERS
38
unique importers
DESTINATIONS
33
countries
MEDIAN UNIT PRICE
$0.515
per unit
TOP-5 SHARE
99.4%
of total USD
BRANDED SHARE
40.7%
35 shipments
DOSAGE FORMS
3
product types
6 KEY FINDINGS
1
MACLEODS PHARMACEUTICALS LTD is India's #1 Isoniazid exporter with $1.8M (63.3% market share).→ §5, Indian Supplier Rankings
2
Isoniazid reached 33 countries, with South Africa as the top destination ($925.0K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 4891) — top 10 suppliers control 100.0% of exports.→ §5, Indian Supplier Rankings
4
89.5% of buyers (34 of 38) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (94.0%) across 3 dosage forms.→ §7, Price Benchmarks
6
33 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 MACLEODS PHARMACEUTICALS LTD leads in volume — how do 19 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian isoniazid exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Isoniazid report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial isoniazid trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian isoniazid suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Isoniazid India trade report
Product scope
Isoniazid
All variants merged — branded and generic formulations of isoniazid
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
86
Every commercial isoniazid trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $1.1M, Nov $1.2M, Dec $568.0K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$1.1M
Oct USD
12 shipments
2
$1.2M
Nov USD
+15.0% MoM
3
$568.0K
Dec USD
-53.0% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 15.0% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $1.1M, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $2.8M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $158K rise in Nov, $641K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $1.1M | 12 shipments |
| Nov | $1.2M | 43 shipments |
| Dec | $568K | 31 shipments |
| Q4 Total | $2.8M | 86 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: South Africa held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: LUPIN LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import isoniazid from India, how much they buy, and who supplies each market
KEY TAKEAWAY
South Africa absorbs 32.7% of India’s 2025-Q4 isoniazid trade ($925.0K). Beyond the top 10 destinations, 33 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 13 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 33 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much isoniazid India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$123K
4.4% of trade
12 countries · 34 shipments
Europe
$237
0.0% of trade
1 countries · 1 shipments
Americas
$174K
6.1% of trade
6 countries · 9 shipments
Africa
$2.5M
89.5% of trade
13 countries · 41 shipments
Oceania
$14
0.0% of trade
1 countries · 1 shipments
Fig 4.1 South Africa is the #1 corridor ($925K) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian isoniazid it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | South Africa | $925K | 18 | LUPIN LTD | $824K | MACLEODS PHARMACEUTICALS LTD | $101K | — | — |
| 2 | Zimbabwe | $712K | 4 | MACLEODS PHARMACEUTICALS LTD | $712K | — | — | — | — |
| 3 | Mozambique | $671K | 2 | MACLEODS PHARMACEUTICALS LTD | $671K | — | — | — | — |
| 4 | Guyana | $99K | 2 | MACLEODS PHARMACEUTICALS LTD | $99K | — | — | — | — |
| 5 | Benin | $84K | 1 | MACLEODS PHARMACEUTICALS LTD | $84K | — | — | — | — |
| 6 | Myanmar | $77K | 2 | MACLEODS PHARMACEUTICALS LTD | $75K | LUPIN LTD | $2K | — | — |
| 7 | United States | $58K | 1 | ALKEM LABORATORIES LTD | $58K | — | — | — | — |
| 8 | Kenya | $55K | 1 | MICRO LABS LTD | $55K | — | — | — | — |
| 9 | Nepal | $26K | 2 | MACLEODS PHARMACEUTICALS LTD | $26K | — | — | — | — |
| 10 | DR Congo | $24K | 1 | BIOMATRIX HEALTHCARE PVT LTD | $24K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 4.4% of USD — but South Africa is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
32.7%
#1 country share
South Africa alone
88.1%
Top 5 share
5 of 33 countries
99.4%
Top 15 share
Long tail of 18 countries = 0.6%
HHI 2306
Destination HHI
Moderately concentrated
33
Countries served
Global pharma reach from India
13
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
19 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
MACLEODS PHARMACEUTICALS LTD ($1.8M, 63.3% share) and LUPIN LTD ($830.1K) together control 92.7% of India’s 2025-Q4 isoniazid trade. The top 5 suppliers hold 99.4%. 19 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian isoniazid suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 MACLEODS PHARMACEUTICALS LTD leads by $961K over LUPIN LTD — top 19 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: MOVID IMPEX is #18 by value but #7 by volume.
Fig 5.2 MACLEODS PHARMACEUTICALS LTD also leads by shipment count (25) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: MOVID IMPEX moves from #7 by volume to #18 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 19 isoniazid suppliers split into strategic segments
KEY TAKEAWAY
5 suppliers (25%) generate 99.4% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 MACLEODS PHARMACEUTICALS LTD and LUPIN LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 99.4% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD | 2 | 12 | $1.8M |
| 2 | LUPIN LTD | 1 | 5 | $830K |
| 3 | MICRO LABS LTD | 1 | 6 | $107K |
| 4 | ALKEM LABORATORIES LTD | 1 | 1 | $58K |
| 5 | BIOMATRIX HEALTHCARE PVT LTD | 1 | 1 | $24K |
| 6 | SAMRUDH PHARMACEUTICALS PVT LTD | 1 | 1 | $10K |
| 7 | SWETA DISTRIBUTORS PVT LTD | 1 | 1 | $2K |
| 8 | WORLD HEALTH ORGANIZATION | 1 | 1 | $2K |
| 9 | HINDAZ.CORP | 1 | 1 | $2K |
| 10 | VATS INDUSTRIES PVT LTD | 1 | 1 | $870 |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the isoniazid manufacturing hubs
KEY TAKEAWAY
Village Dukheri Po Mohra and Mumbai together account for $2.4M of India’s 2025-Q4 isoniazid trade.
Fig 5.5 Village Dukheri Po Mohra (1 exporters, $1.6M) and Mumbai (2 exporters, $830K) are India’s isoniazid capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
99.4%
Top 5 share
5 of 19 suppliers
100.0%
Top 10 share
10 of 19 suppliers
99.4%
Top 25% share
5 suppliers = 99% USD
HHI 4891
Supplier HHI
Concentrated
19
Total suppliers
shipped Isoniazid in 2025-Q4
19+ cities
Indian hubs
Village Dukheri Po Mohra and Mumbai lead
§5.2 Coming next: 3 exporter deep-dive profiles
Each of the top 3 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | MACLEODS PHARMACEUTICALS LTD | $1.8M |
| #2 | LUPIN LTD | $830K |
| #3 | MICRO LABS LTD | $107K |
#1
EXPORTER PROFILE #1 OF 3
MACLEODS PHARMACEUTICALS LTD
Village Dukheri Po Mohra · India’s #1 isoniazid supplier by USD · 2025-Q4
2025-Q4 USD
$1.8M
63.3% market share
SHIPMENTS
25
avg $72K/ship
COUNTRIES
12
destination markets
BUYERS
13
11 single-sourced
BRANDED
20%
of shipments
DOSAGE FORMS
2
product types
TOP 10 DESTINATIONS
Zimbabwe is the #1 market at $712K (40% of trade), followed by Mozambique at $671K. 12 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Zimbabwe | $712K | 4 | 39.8% |
| 2 | Mozambique | $671K | 2 | 37.5% |
| 3 | South Africa | $101K | 3 | 5.7% |
| 4 | Guyana | $99K | 2 | 5.5% |
| 5 | Benin | $84K | 1 | 4.7% |
| 6 | Myanmar | $75K | 1 | 4.2% |
| 7 | Nepal | $26K | 2 | 1.5% |
| 8 | Colombia | $11K | 1 | 0.6% |
| 9 | Eswatini | $10K | 1 | 0.6% |
| 10 | Thailand | $493 | 1 | 0.0% |
MONTHLY TREND
Nov peaked at $931K. Dec was the weakest at $21K.
PRODUCT MIX
Tablet dominates at 91% of trade. Dispersible Tablet (8.9%) and others are secondary formulations.
TOP BUYERS · 11/13 LOCKED IN
11 of 13 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| MINISTRY OF HEALTH & C… | Zimbabwe | $712K | ⚠ Locked |
| PS -MOHCC - DPS (C) | Mozambique | $671K | ⚠ Locked |
| NEW GPC INC | Guyana | $99K | ⚠ Locked |
| MACLEODS PHARMACEUTICA… | South Africa | $92K | ⚠ Locked |
| PROGRAMME NATIONAL CON… | Benin | $84K | ⚠ Locked |
| UNOPS ARHC - .NO. 12(O… | Myanmar | $75K | ⚠ Locked |
| AMERICAN EMBASSY (USAID) | Nepal | $26K | ⚠ Locked |
| NATIONAL EMERGENCY RES… | Eswatini | $19K | ⚠ Locked |
| MINISTERIO DE SA | Colombia | $11K | 2 sup. |
| M.S. TERMINAL CO LTD | Thailand | $493 | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 3 — TRADE FLOW MAP
MACLEODS PHARMACEUTICALS LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P1.3 Zimbabwe absorbs $712K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#2
2025-Q4 USD
$830K
29.3% market share
SHIPMENTS
22
avg $38K/ship
COUNTRIES
5
destination markets
BUYERS
6
4 single-sourced
BRANDED
59%
of shipments
DOSAGE FORMS
1
product types
TOP 5 DESTINATIONS
South Africa is the #1 market at $824K (99% of trade), followed by Venezuela at $3K. 5 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | South Africa | $824K | 15 | 99.2% |
| 2 | Venezuela | $3K | 3 | 0.3% |
| 3 | Myanmar | $2K | 1 | 0.2% |
| 4 | Yemen | $997 | 2 | 0.1% |
| 5 | Ecuador | $555 | 1 | 0.1% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $495K.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 4/6 LOCKED IN
4 of 6 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| XEON LOGISTICS | South Africa | $669K | ⚠ Locked |
| UPD LEA GLEN, PHARMA D… | South Africa | $155K | ⚠ Locked |
| UNDP IN VENEZUELA CLAU… | Venezuela | $3K | ⚠ Locked |
| UNOPS | Myanmar | $2K | ⚠ Locked |
| INTERNATIONAL ORGANIZA… | Yemen | $997 | 2 sup. |
| MINISTERIO DE SA | Ecuador | $555 | 2 sup. |
#2
EXPORTER PROFILE #2 OF 3 — TRADE FLOW MAP
LUPIN LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P2.3 South Africa absorbs $824K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#3
2025-Q4 USD
$107K
3.8% market share
SHIPMENTS
13
avg $8K/ship
COUNTRIES
6
destination markets
BUYERS
7
6 single-sourced
BRANDED
31%
of shipments
DOSAGE FORMS
1
product types
TOP 6 DESTINATIONS
Kenya is the #1 market at $55K (51% of trade), followed by Algeria at $24K. 6 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Kenya | $55K | 1 | 51.4% |
| 2 | Algeria | $24K | 8 | 22.6% |
| 3 | Angola | $24K | 1 | 22.4% |
| 4 | Chile | $3K | 1 | 3.0% |
| 5 | Uganda | $683 | 1 | 0.6% |
| 6 | Sudan | $28 | 1 | 0.0% |
MONTHLY TREND
Oct peaked at $58K. Dec was the weakest at $24K.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 6/6 LOCKED IN
6 of 6 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| UNDP OFFICE IN SOUTH S… | Kenya | $55K | ⚠ Locked |
| UNDP/GLOBAL FUND PROJECT | Angola | $24K | ⚠ Locked |
| PHARMACIE CENTRALE DES… | Algeria | $12K | ⚠ Locked |
| Undisclosed buyer | Algeria | $12K | N/A |
| CENTRAL DE ABASTECIMIE… | Chile | $3K | ⚠ Locked |
| MEDICAL ACCESS UGANDA … | Uganda | $683 | ⚠ Locked |
| FEDERALMINISTRYOFHEALT… | Sudan | $28 | ⚠ Locked |
#3
EXPORTER PROFILE #3 OF 3 — TRADE FLOW MAP
MICRO LABS LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P3.3 Kenya absorbs $55K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
38 importers across 33 countries — who is buying Indian isoniazid and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 99.5% of total USD. 89% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian isoniazid. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 MINISTRY OF HEALTH & CHIL is the #1 importer at $712K (25.2%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
89%
Single-source
34 buyers rely on exactly 1 Indian supplier
8%
Dual-source
3 buyers use 2 Indian suppliers
3%
Multi-source (3–4)
1 buyers diversified across 3–4
0%
Broad-source (5+)
0 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source isoniazid from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
South Africa 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| XEON LOGISTICS | LUPIN LTD | $669K | $1.718 | Tablet |
| UPD LEA GLEN, PHARMA D… | LUPIN LTD | $155K | $0.515 | Tablet |
| MACLEODS PHARMACEUTICA… | MACLEODS PHARMACEUTI… | $92K | $0.020 | Tablet |
United Arab Emirates 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| HEALTHDECK DRUG STORE … | SWETA DISTRIBUTORS P… | $2K | $0.714 | Tablet |
| THE HEALINGS PLACE NAT… | WORLDWIDE AYURHUB PV… | $119.037 | $0.397 | Tablet |
| EMIRATES POST GROUP | MOVID IMPEX | $1.139 | $0.127 | Tablet |
Myanmar 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| UNOPS ARHC - .NO. 12(O… | MACLEODS PHARMACEUTI… | $75K | $0.090 | Dispersible Tablet |
| UNOPS | LUPIN LTD | $2K | $1.019 | Tablet |
Sri Lanka 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| WORLD HEALTH ORGANIZAT… | WORLD HEALTH ORGANIZ… | $2K | $144.912 | Tablet |
| NATIONAL MEDICAL STORE | NILA PHARMACEUTICALS | $143.307 | $0.0080 | Tablet |
Zimbabwe 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MINISTRY OF HEALTH & C… | MACLEODS PHARMACEUTI… | $712K | $0.316 | Tablet |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | MINISTRY OF HEALTH &… | Zimbabwe | $712K | $178K | Premium |
| 2 | PS -MOHCC - DPS (C) | Mozambique | $671K | $336K | Premium |
| 3 | XEON LOGISTICS | South Africa | $669K | $67K | Premium |
| 4 | UPD LEA GLEN, PHARMA… | South Africa | $155K | $31K | Mid |
| 5 | NEW GPC INC | Guyana | $99K | $49K | Premium |
| 6 | MACLEODS PHARMACEUTI… | South Africa | $92K | $92K | Premium |
| 7 | PROGRAMME NATIONAL C… | Benin | $84K | $84K | Premium |
| 8 | UNOPS ARHC - .NO. 12… | Myanmar | $75K | $75K | Premium |
| 9 | ASCEND LABORATORIES … | United States | $58K | $58K | Premium |
| 10 | UNDP OFFICE IN SOUTH… | Kenya | $55K | $55K | Premium |
| 11 | AMERICAN EMBASSY (US… | Nepal | $26K | $13K | Budget |
| 12 | UNIQUE PHARMA | DR Congo | $24K | $24K | Mid |
| 13 | UNDP/GLOBAL FUND PRO… | Angola | $24K | $24K | Mid |
| 14 | NATIONAL EMERGENCY R… | Eswatini | $19K | $6K | Budget |
| 15 | PHARMACIE CENTRALE D… | Algeria | $12K | $3K | Budget |
| 16 | MINISTERIO DE SA | Ecuador | $12K | $6K | Budget |
| 17 | CAMEL INTERNATIONAL … | Vietnam | $10K | $10K | Budget |
| 18 | CENTRAL DE ABASTECIM… | Chile | $3K | $3K | Budget |
| 19 | UNDP IN VENEZUELA CL… | Venezuela | $3K | $956.000 | Budget |
| 20 | HEALTHDECK DRUG STOR… | United Arab Emirates | $2K | $1K | Budget |
| 21 | WORLD HEALTH ORGANIZ… | Sri Lanka | $2K | $2K | Budget |
| 22 | SIFAT PHARMA LLC | Tajikistan | $2K | $513.000 | Budget |
| 23 | UNOPS | Myanmar | $2K | $2K | Budget |
| 24 | INTERNATIONAL ORGANI… | Yemen | $1K | $405.000 | Budget |
| 25 | MEDICAL ACCESS UGAND… | Uganda | $682.935 | $683.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 19 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 MACLEODS PHARMACEUTICALS LTD → MINISTRY OF HEALTH & CHIL is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 19 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian isoniazid prices vary by supplier, country and dosage form
KEY TAKEAWAY
Isoniazid prices span 743480× ($0.0002 → $144.91). The coefficient of variation is 4.06. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0002 | Lowest observed unit price |
| P5 | $0.0016 | 5th percentile |
| P25 | $0.088 | 25th percentile (Q1) |
| Median | $0.515 | 50th percentile (Q2) |
| P75 | $1.07 | 75th percentile (Q3) |
| P95 | $12.68 | 95th percentile |
| Max | $144.91 | Highest observed unit price |
| Mean | $4.16 | Arithmetic average |
| CV | 406% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 WORLD HEALTH ORGANIZATION prices at $144.91/unit vs market median $0.515.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. MACLEODS PHARMACEUTICALS LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. LUPIN LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | WORLD HEALTH ORG… | Sri Lanka | Tablet | 15 | $2K | $144.91 | Specialty / small-batch |
| Dec 2025 | BIOMATRIX HEALTH… | DR Congo | Tablet | 485 | $24K | $50.16 | Specialty / small-batch |
| Dec 2025 | LUPIN LTD | South Africa | Tablet | 19K | $345K | $17.68 | Specialty / small-batch |
| Nov 2025 | MICRO LABS LTD | Uganda | Tablet | 50 | $682.94 | $13.66 | Specialty / small-batch |
| Oct 2025 | MICRO LABS LTD | Kenya | Tablet | 4K | $55K | $12.74 | Specialty / small-batch |
| Dec 2025 | MICRO LABS LTD | Angola | Tablet | 2K | $24K | $11.68 | Specialty / small-batch |
| Dec 2025 | LUPIN LTD | South Africa | Tablet | 13K | $140K | $10.95 | Specialty / small-batch |
| Nov 2025 | HINDAZ.CORP | Tajikistan | Tablet | 45 | $492.15 | $10.94 | Specialty / small-batch |
| Nov 2025 | HINDAZ.CORP | Tajikistan | Tablet | 45 | $492.15 | $10.94 | Specialty / small-batch |
| Dec 2025 | LUPIN LTD | South Africa | Tablet | 1K | $9K | $7.80 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | BARAKAH BIOHEALT… | Saudi Arabia | Tablet | 200 | $0.303 | $0.0015 | Bulk generic tablet |
| Dec 2025 | MACLEODS PHARMAC… | Yemen | Tablet | 2K | $6.59 | $0.0032 | Bulk generic tablet |
| Nov 2025 | MICRO LABS LTD | Algeria | Tablet | 2 | $0.0091 | $0.0046 | Bulk generic tablet |
| Nov 2025 | MICRO LABS LTD | Algeria | Tablet | 2 | $0.0091 | $0.0046 | Bulk generic tablet |
| Nov 2025 | MICRO LABS LTD | Algeria | Tablet | 2 | $0.0091 | $0.0046 | Bulk generic tablet |
| Nov 2025 | MICRO LABS LTD | Algeria | Tablet | 2 | $0.0091 | $0.0046 | Bulk generic tablet |
| Oct 2025 | NILA PHARMACEUTI… | Sri Lanka | Tablet | 18K | $143.31 | $0.0080 | Bulk generic tablet |
| Nov 2025 | PAXTER LIFESCIEN… | Morocco | Dispersible Tablet | 45K | $378.58 | $0.0084 | Bulk generic tablet |
| Dec 2025 | MACLEODS PHARMAC… | South Africa | Tablet | 56K | $710.78 | $0.013 | |
| Nov 2025 | MACLEODS PHARMAC… | Nepal | Tablet | 198K | $3K | $0.015 |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship isoniazid, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Isoniazid leaves India through 10+ ports. The top 5 (DELHI AIR, NHAVA SHEVA SEA (JNPT), MUNDRA SEA) handle 99.3% of total USD. SEA moves 37% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 DELHI AIR handles $1.0M — top 10 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Durban is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 37% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$1.7M
59.2% of USD · 37.2% of ships
AIR
$1.1M
39.9% of USD · 61.6% of ships
ICD
$24K
0.9% of USD · 1.2% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → Africa ($925K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Algeria is the most concentrated destination (HHI 10000, 1 suppliers). Yemen is the most competitive (HHI 5657).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Algeria (HHI 10,000) is the most concentrated — Yemen (HHI 5,657) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| MINISTRY OF HEALTH &… | Zimbabwe | MACLEODS PHARMAC… | $712K | 4 | CRITICAL |
| PS -MOHCC - DPS (C) | Mozambique | MACLEODS PHARMAC… | $671K | 2 | CRITICAL |
| XEON LOGISTICS | South Africa | LUPIN LTD | $669K | 10 | CRITICAL |
| UPD LEA GLEN, PHARMA… | South Africa | LUPIN LTD | $155K | 5 | HIGH |
| NEW GPC INC | Guyana | MACLEODS PHARMAC… | $99K | 2 | MEDIUM |
| MACLEODS PHARMACEUTI… | South Africa | MACLEODS PHARMAC… | $92K | 1 | MEDIUM |
| PROGRAMME NATIONAL C… | Benin | MACLEODS PHARMAC… | $84K | 1 | MEDIUM |
| UNOPS ARHC - .NO. 12… | Myanmar | MACLEODS PHARMAC… | $75K | 1 | MEDIUM |
Conclusion: 34 buyers depend on exactly one Indian supplier, representing $2.8M in trade. 3 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| South Africa | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Zimbabwe | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Mozambique | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Guyana | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Benin | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Myanmar | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nepal | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| DR Congo | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Algeria | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Angola | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Colombia | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Eswatini | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Vietnam | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Zimbabwe | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Algeria lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter South Africa (2 suppliers) | This Q | HIGH |
| A6 | Enter Zimbabwe (1 suppliers) | This Q | MED |
| A8 | Build Zimbabwe distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for South Africa tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | South Africa | Africa | 2 | $925K | +104% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Zimbabwe | Africa | 1 | $712K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Mozambique | Africa | 1 | $671K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Guyana | Other | 1 | $99K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Benin | Africa | 1 | $84K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Myanmar | Asia | 2 | $77K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | United States | Other | 1 | $58K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Kenya | Africa | 1 | $55K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Nepal | Asia | 1 | $26K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | DR Congo | Africa | 1 | $24K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Algeria | Africa | 1 | $24K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Angola | Africa | 1 | $24K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Colombia | Other | 1 | $11K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Eswatini | Africa | 1 | $10K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Vietnam | Asia | 1 | $10K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 86 2025-Q4 Isoniazid shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/isoniazid
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 86 2025-Q4 isoniazid shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian isoniazid shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
86
across all regions
TOTAL USD
$2.83M
2025-Q4 FOB value
UNITS
16.5M
tablets, capsules, etc.
SUPPLIERS
19
Indian exporters
BUYERS
38
global importers
COUNTRIES
33
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $2.53M (89.5%), spanning 13 countries.
19 Indian suppliers shipped to 38 buyers across 33 countries — average shipment value $33K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
13 countries · 41 shipments · $2.53M · 6 Indian suppliers · 16 buyers
SHIPMENTS
41
USD
$2.53M
COUNTRIES
13
SUPPLIERS
6
BUYERS
16
HHI
4,967
concentrated
Top 13 destination countries in Africa
1
South Africa (36.5%)
$925K
2
Zimbabwe (28.1%)
$712K
3
Mozambique (26.5%)
$671K
4
Benin (3.3%)
$84K
5
Kenya (2.2%)
$55K
6
DR Congo (1.0%)
$24K
7
Algeria (1.0%)
$24K
8
Angola (0.9%)
$24K
9
Eswatini (0.4%)
$10K
10
Uganda (0.0%)
$682.94
11
Morocco (0.0%)
$378.58
12
Sudan (0.0%)
$27.55
13
Ghana (0.0%)
$3.06
Top 6 Indian suppliers into Africa
1
MACLEODS PHARMACEUTICALS LTD
$1.58M
2
LUPIN LTD
$824K
3
MICRO LABS LTD
$104K
4
BIOMATRIX HEALTHCARE PVT LTD
$24K
5
PAXTER LIFESCIENCES
$378.58
6
RUTVA MEDICARE
$3.06
Top 14 Africa importers
1
MINISTRY OF HEALTH & CHIL · Zimbabwe
$712K
2
PS -MOHCC - DPS (C) · Mozambique
$671K
3
XEON LOGISTICS · South Africa
$669K
4
UPD LEA GLEN, PHARMA DYNAMICS · South Africa
$155K
5
MACLEODS PHARMACEUTICALS SA · South Africa
$92K
6
PROGRAMME NATIONAL CONTRE LA · Benin
$84K
7
UNDP OFFICE IN SOUTH SUDAN · Kenya
$55K
8
UNIQUE PHARMA · DR Congo
$24K
9
UNDP/GLOBAL FUND PROJECT · Angola
$24K
10
NATIONAL EMERGENCY RESPONSE COUNCIL · Eswatini
$19K
11
PHARMACIE CENTRALE DES HOPITAUX · Algeria
$12K
12
MEDICAL ACCESS UGANDA LTD · Uganda
$682.94
13
PHARMAPROM · Morocco
$378.58
14
FEDERALMINISTRYOFHEALTH(FMOH) · Sudan
$27.55
Top 2 dosage forms
1
Tablet
$2.45M
2
Dispersible Tablet
$85K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 9 | $973K | $108K |
| Nov | 22 | $1.01M | $46K |
| Dec | 10 | $552K | $55K |
Shipment register · 41 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MACLEODS PHARMACEUTICALS LTD · 11 shipments · $1.58M | |||||||||||
| 1 | Oct 2025 | PS -MOHCC - DPS (C) | Mozambique | Tablet | 1.1M | NOS | $0.311 | $336K | MUNDRA SEA | BEIRA | SEA |
| 2 | Oct 2025 | PS -MOHCC - DPS (C) | Mozambique | Tablet | 1.1M | NOS | $0.311 | $336K | MUNDRA SEA | Beira | SEA |
| 3 | Oct 2025 | MACLEODS PHARMACEUTICALS SA | South Africa | Tablet | 4.6M | NOS | $0.020 | $92K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 4 | Nov 2025 | MINISTRY OF HEALTH & CHIL | Zimbabwe | Tablet | 604.8K | NOS | $0.316 | $191K | DELHI AIR | HARARE | AIR |
| 5 | Nov 2025 | MINISTRY OF HEALTH & CHIL | Zimbabwe | Tablet | 549.0K | NOS | $0.316 | $174K | DELHI AIR | HARARE | AIR |
| 6 | Nov 2025 | MINISTRY OF HEALTH & CHIL | Zimbabwe | Tablet | 549.0K | NOS | $0.316 | $174K | DELHI AIR | HARARE | AIR |
| 7 | Nov 2025 | MINISTRY OF HEALTH & CHIL | Zimbabwe | Tablet | 549.0K | NOS | $0.316 | $174K | DELHI AIR | HARARE | AIR |
| 8 | Nov 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | Eswatini | Tablet | 584.0K | NOS | $0.017 | $10K | DELHI AIR | MATADI | AIR |
| 9 | Nov 2025 | PROGRAMME NATIONAL CONTRE LA | Benin | Dispersible Tablet | 969.9K | NOS | $0.087 | $84K | DELHI AIR | COTONOU | AIR |
| 10 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 56.2K | NOS | $0.013 | $710.78 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 11 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 479.1K | NOS | $0.017 | $8K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| SUPPLIER #2 — LUPIN LTD · 15 shipments · $824K | |||||||||||
| 12 | Oct 2025 | UPD LEA GLEN, PHARMA DYNAMICS | South Africa | Tablet | 61.0K | NOS | $0.515 | $31K | NHAVA SHEVA SEA (JNPT) | Johannesburg | SEA |
| 13 | Oct 2025 | UPD LEA GLEN, PHARMA DYNAMICS | South Africa | Tablet | 55.8K | NOS | $0.515 | $29K | NHAVA SHEVA SEA (JNPT) | Johannesburg | SEA |
| 14 | Oct 2025 | UPD LEA GLEN, PHARMA DYNAMICS | South Africa | Tablet | 56.3K | NOS | $0.515 | $29K | NHAVA SHEVA SEA (JNPT) | Johannesburg | SEA |
| 15 | Oct 2025 | UPD LEA GLEN, PHARMA DYNAMICS | South Africa | Tablet | 66.0K | NOS | $0.515 | $34K | NHAVA SHEVA SEA (JNPT) | Johannesburg | SEA |
| 16 | Oct 2025 | UPD LEA GLEN, PHARMA DYNAMICS | South Africa | Tablet | 60.9K | NOS | $0.515 | $31K | NHAVA SHEVA SEA (JNPT) | Johannesburg | SEA |
| 17 | Nov 2025 | XEON LOGISTICS | South Africa | Tablet | 63.1K | NOS | $0.536 | $34K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 18 | Nov 2025 | XEON LOGISTICS | South Africa | Tablet | 61.6K | NOS | $0.535 | $33K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 19 | Nov 2025 | XEON LOGISTICS | South Africa | Tablet | 63.7K | NOS | $0.536 | $34K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 20 | Nov 2025 | XEON LOGISTICS | South Africa | Tablet | 34.7K | NOS | $0.537 | $19K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 21 | Nov 2025 | XEON LOGISTICS | South Africa | Tablet | 66.2K | NOS | $0.538 | $36K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 22 | Nov 2025 | XEON LOGISTICS | South Africa | Tablet | 38.3K | NOS | $0.515 | $20K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 23 | Dec 2025 | XEON LOGISTICS | South Africa | Tablet | 28.6K | NOS | $0.015 | $435.03 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 24 | Dec 2025 | XEON LOGISTICS | South Africa | Tablet | 12.8K | NOS | $10.95 | $140K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 25 | Dec 2025 | XEON LOGISTICS | South Africa | Tablet | 19.5K | NOS | $17.68 | $345K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 26 | Dec 2025 | XEON LOGISTICS | South Africa | Tablet | 1.1K | NOS | $7.80 | $9K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| SUPPLIER #3 — MICRO LABS LTD · 12 shipments · $104K | |||||||||||
| 27 | Oct 2025 | UNDP OFFICE IN SOUTH SUDAN | Kenya | Tablet | 4.3K | PCS | $12.74 | $55K | BANGALORE AIR | NAIROBI | AIR |
| 28 | Nov 2025 | MEDICAL ACCESS UGANDA LTD | Uganda | Tablet | 50 | PCS | $13.66 | $682.94 | BANGALORE AIR | ENTEBBE | AIR |
| 29 | Nov 2025 | PHARMACIE CENTRALE DES HOPITAUX | Algeria | Tablet | 2.6K | PCS | $2.33 | $6K | BANGALORE AIR | ALGIERS | AIR |
| 30 | Nov 2025 | PHARMACIE CENTRALE DES HOPITAUX | Algeria | Tablet | 2 | PCS | $0.0046 | $0.0091 | BANGALORE AIR | ALGIERS | AIR |
| 31 | Nov 2025 | PHARMACIE CENTRALE DES HOPITAUX | Algeria | Tablet | 2.6K | PCS | $2.33 | $6K | BANGALORE AIR | ALGIERS | AIR |
| 32 | Nov 2025 | PHARMACIE CENTRALE DES HOPITAUX | Algeria | Tablet | 2 | PCS | $0.0046 | $0.0091 | BANGALORE AIR | ALGIERS | AIR |
| 33 | Nov 2025 | UNKNOWN BUYER | Algeria | Tablet | 2.6K | PCS | $2.33 | $6K | BANGALORE AIR | ALGIERS | AIR |
| 34 | Nov 2025 | UNKNOWN BUYER | Algeria | Tablet | 2 | PCS | $0.0046 | $0.0091 | BANGALORE AIR | ALGIERS | AIR |
| 35 | Nov 2025 | UNKNOWN BUYER | Algeria | Tablet | 2.6K | PCS | $2.33 | $6K | BANGALORE AIR | ALGIERS | AIR |
| 36 | Nov 2025 | UNKNOWN BUYER | Algeria | Tablet | 2 | PCS | $0.0046 | $0.0091 | BANGALORE AIR | ALGIERS | AIR |
| 37 | Dec 2025 | FEDERALMINISTRYOFHEALTH(FMOH) | Sudan | Tablet | 209 | PCS | $0.132 | $27.55 | BANGALORE AIR | KHARTOUM | AIR |
| 38 | Dec 2025 | UNDP/GLOBAL FUND PROJECT | Angola | Tablet | 2.1K | PCS | $11.68 | $24K | BANGALORE AIR | LUANDA - | AIR |
| SUPPLIER #4 — BIOMATRIX HEALTHCARE PVT LTD · 1 shipments · $24K | |||||||||||
| 39 | Dec 2025 | UNIQUE PHARMA | DR Congo | Tablet | 485 | THD | $50.16 | $24K | AHMEDABAD ICD | MATADI | ICD |
| SUPPLIER #5 — PAXTER LIFESCIENCES · 1 shipments · $378.58 | |||||||||||
| 40 | Nov 2025 | PHARMAPROM | Morocco | Dispersible Tablet | 45.0K | NOS | $0.0084 | $378.58 | AHMEDABAD AIR | CASABLANCA, MOHAMED | AIR |
| SUPPLIER #6 — RUTVA MEDICARE · 1 shipments · $3.06 | |||||||||||
| 41 | Dec 2025 | UNLISTED BUYER | Ghana | Tablet | 30 | PCS | $0.102 | $3.06 | AHMEDABAD AIR | ACCRA | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
12 countries · 34 shipments · $123K · 12 Indian suppliers · 18 buyers
SHIPMENTS
34
USD
$123K
COUNTRIES
12
SUPPLIERS
12
BUYERS
18
HHI
7,024
concentrated
Top 12 destination countries in Asia
1
Myanmar (62.5%)
$77K
2
Nepal (21.4%)
$26K
3
Vietnam (7.7%)
$10K
4
United Arab Emirates (2.1%)
$3K
5
Sri Lanka (1.9%)
$2K
6
Tajikistan (1.7%)
$2K
7
Yemen (1.2%)
$1K
8
Iraq (0.7%)
$870.31
9
Thailand (0.4%)
$492.89
10
Cambodia (0.2%)
$292.35
11
Indonesia (0.2%)
$268.35
12
Saudi Arabia (0.0%)
$0.303
Top 12 Indian suppliers into Asia
1
MACLEODS PHARMACEUTICALS LTD
$103K
2
SAMRUDH PHARMACEUTICALS PVT LTD
$10K
3
LUPIN LTD
$3K
4
SWETA DISTRIBUTORS PVT LTD
$2K
5
WORLD HEALTH ORGANIZATION
$2K
6
HINDAZ.CORP
$2K
7
VATS INDUSTRIES PVT LTD
$870.31
8
SVIZERA LABS PVT LTD
$268.35
9
NILA PHARMACEUTICALS
$143.31
10
WORLDWIDE AYURHUB PVT LTD
$119.04
11
MOVID IMPEX
$1.14
12
BARAKAH BIOHEALTH LLP
$0.303
Top 16 Asia importers
1
UNOPS ARHC - .NO. 12(O)PYI THU LANE · Myanmar
$75K
2
AMERICAN EMBASSY (USAID) · Nepal
$26K
3
CAMEL INTERNATIONAL IM-EXPORT CO LT · Vietnam
$10K
4
HEALTHDECK DRUG STORE LLC · United Arab Emirates
$2K
5
WORLD HEALTH ORGANIZATION · Sri Lanka
$2K
6
SIFAT PHARMA LLC · Tajikistan
$2K
7
UNOPS · Myanmar
$2K
8
INTERNATIONAL ORGANIZATION FOR MIGR · Yemen
$1K
9
ATLAS TRADING COMPANY · Iraq
$642.78
10
M.S. TERMINAL CO LTD · Thailand
$492.89
11
CENAT (NATIONAL CENTER FOR · Cambodia
$292.35
12
SEKRETARIAT DITJEN PENCEGAHAN DAN · Indonesia
$268.35
13
INTERNATIONAL ORGANIZATION FOR · Yemen
$247.20
14
NATIONAL MEDICAL STORE · Sri Lanka
$143.31
15
THE HEALINGS PLACE NATURAL HERBS · United Arab Emirates
$119.04
16
EMIRATES POST GROUP · United Arab Emirates
$1.14
Top 3 dosage forms
1
Dispersible Tablet
$75K
2
Tablet
$39K
3
Injection
$10K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $75K | $38K |
| Nov | 14 | $43K | $3K |
| Dec | 18 | $5K | $280.37 |
Shipment register · 34 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MACLEODS PHARMACEUTICALS LTD · 11 shipments · $103K | |||||||||||
| 1 | Oct 2025 | UNOPS ARHC - .NO. 12(O)PYI THU LANE | Myanmar | Dispersible Tablet | 837.5K | NOS | $0.090 | $75K | NHAVA SHEVA SEA (JNPT) | Yangon | SEA |
| 2 | Nov 2025 | AMERICAN EMBASSY (USAID) | Nepal | Tablet | 198.4K | NOS | $0.015 | $3K | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 3 | Nov 2025 | AMERICAN EMBASSY (USAID) | Nepal | Tablet | 1.3M | NOS | $0.018 | $23K | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 4 | Dec 2025 | CENAT (NATIONAL CENTER FOR | Cambodia | Tablet | 1 | NOS | $0.0000 | $0.0000 | DELHI AIR | PHNOM PENH - POCHENT | AIR |
| 5 | Dec 2025 | CENAT (NATIONAL CENTER FOR | Cambodia | Tablet | 294.7K | NOS | $0.0010 | $292.35 | DELHI AIR | PHNOM PENH - POCHENT | SEA |
| 6 | Dec 2025 | INTERNATIONAL ORGANIZATION FOR | Yemen | Tablet | 2.1K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Aden | SEA |
| 7 | Dec 2025 | INTERNATIONAL ORGANIZATION FOR | Yemen | Tablet | 2.1K | NOS | $0.0032 | $6.59 | NHAVA SHEVA SEA (JNPT) | Aden | SEA |
| 8 | Dec 2025 | INTERNATIONAL ORGANIZATION FOR MIGR | Yemen | Tablet | 1.1M | NOS | $0.0002 | $219.13 | NHAVA SHEVA SEA (JNPT) | Aden | AIR |
| 9 | Dec 2025 | INTERNATIONAL ORGANIZATION FOR | Yemen | Tablet | 439.5K | NOS | $0.0002 | $85.66 | NHAVA SHEVA SEA (JNPT) | Aden | SEA |
| 10 | Dec 2025 | INTERNATIONAL ORGANIZATION FOR | Yemen | Tablet | 156.2K | NOS | $0.0010 | $154.95 | NHAVA SHEVA SEA (JNPT) | Aden | SEA |
| 11 | Dec 2025 | M.S. TERMINAL CO LTD | Thailand | Tablet | 25.5K | NOS | $0.019 | $492.89 | DELHI AIR | BANGKOK | AIR |
| SUPPLIER #2 — SAMRUDH PHARMACEUTICALS PVT LTD · 1 shipments · $10K | |||||||||||
| 12 | Nov 2025 | CAMEL INTERNATIONAL IM-EXPORT CO LT | Vietnam | Injection | 17.4K | NOS | $0.549 | $10K | MUMBAI AIR (SAHAR) | HO CHI MINH C | AIR |
| SUPPLIER #3 — LUPIN LTD · 3 shipments · $3K | |||||||||||
| 13 | Nov 2025 | UNOPS | Myanmar | Tablet | 1.9K | NOS | $1.02 | $2K | MUMBAI AIR (SAHAR) | YANGON | AIR |
| 14 | Dec 2025 | INTERNATIONAL ORGANIZATION FOR MIGR | Yemen | Tablet | 1.4K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Aden | AIR |
| 15 | Dec 2025 | INTERNATIONAL ORGANIZATION FOR MIGR | Yemen | Tablet | 1.4K | NOS | $0.725 | $996.70 | NHAVA SHEVA SEA (JNPT) | Aden | SEA |
| SUPPLIER #4 — SWETA DISTRIBUTORS PVT LTD · 2 shipments · $2K | |||||||||||
| 16 | Dec 2025 | HEALTHDECK DRUG STORE LLC | United Arab Emirates | Tablet | 2.1K | NOS | $0.714 | $2K | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 17 | Dec 2025 | HEALTHDECK DRUG STORE LLC | United Arab Emirates | Tablet | 1.2K | NOS | $0.714 | $887.44 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #5 — WORLD HEALTH ORGANIZATION · 1 shipments · $2K | |||||||||||
| 18 | Nov 2025 | WORLD HEALTH ORGANIZATION | Sri Lanka | Tablet | 15 | NOS | $144.91 | $2K | DELHI AIR | COLOMBO | AIR |
| SUPPLIER #6 — HINDAZ.CORP · 4 shipments · $2K | |||||||||||
| 19 | Nov 2025 | SIFAT PHARMA LLC | Tajikistan | Tablet | 45 | NOS | $10.94 | $492.15 | NHAVA SHEVA SEA (JNPT) | Dushanbe | SEA |
| 20 | Nov 2025 | SIFAT PHARMA LLC | Tajikistan | Tablet | 500 | NOS | $1.07 | $534.34 | NHAVA SHEVA SEA (JNPT) | Dushanbe | SEA |
| 21 | Nov 2025 | SIFAT PHARMA LLC | Tajikistan | Tablet | 45 | NOS | $10.94 | $492.15 | NHAVA SHEVA SEA (JNPT) | Dushanbe | SEA |
| 22 | Nov 2025 | SIFAT PHARMA LLC | Tajikistan | Tablet | 500 | NOS | $1.07 | $534.36 | NHAVA SHEVA SEA (JNPT) | Dushanbe | SEA |
| SUPPLIER #7 — VATS INDUSTRIES PVT LTD · 5 shipments · $870.31 | |||||||||||
| 23 | Nov 2025 | ATLAS TRADING COMPANY | Iraq | Tablet | 1.0K | NOS | $0.114 | $113.76 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 24 | Nov 2025 | ATLAS TRADING COMPANY | Iraq | Tablet | 100 | NOS | $4.15 | $415.24 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 25 | Nov 2025 | ATLAS TRADING COMPANY | Iraq | Tablet | 1.0K | NOS | $0.114 | $113.77 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 26 | Nov 2025 | UNKNOWN BUYER | Iraq | Tablet | 1.0K | NOS | $0.114 | $113.76 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 27 | Nov 2025 | UNKNOWN BUYER | Iraq | Tablet | 1.0K | NOS | $0.114 | $113.77 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #8 — SVIZERA LABS PVT LTD · 1 shipments · $268.35 | |||||||||||
| 28 | Dec 2025 | SEKRETARIAT DITJEN PENCEGAHAN DAN | Indonesia | Tablet | 2.4K | NOS | $0.110 | $268.35 | MUMBAI AIR (SAHAR) | JAKARTA | AIR |
| SUPPLIER #9 — NILA PHARMACEUTICALS · 1 shipments · $143.31 | |||||||||||
| 29 | Oct 2025 | NATIONAL MEDICAL STORE | Sri Lanka | Tablet | 18.0K | NOS | $0.0080 | $143.31 | TRIVENDRUM AIR CARGO | CMB | AIR |
| SUPPLIER #10 — WORLDWIDE AYURHUB PVT LTD · 1 shipments · $119.04 | |||||||||||
| 30 | Dec 2025 | THE HEALINGS PLACE NATURAL HERBS | United Arab Emirates | Tablet | 300 | NOS | $0.397 | $119.04 | COCHIN SEA | JEBEL ALI | SEA |
| SUPPLIER #11 — MOVID IMPEX · 2 shipments · $1.14 | |||||||||||
| 31 | Dec 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 1 | NOS | $0.127 | $0.127 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 32 | Dec 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 8 | NOS | $0.127 | $1.01 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #12 — BARAKAH BIOHEALTH LLP · 2 shipments · $0.303 | |||||||||||
| 33 | Dec 2025 | UNLISTED BUYER | Saudi Arabia | Tablet | 200 | NOS | $0.0000 | $0.0000 | CHENNAI AIR | JEDDAH | AIR |
| 34 | Dec 2025 | UNLISTED BUYER | Saudi Arabia | Tablet | 200 | NOS | $0.0015 | $0.303 | CHENNAI AIR | JEDDAH | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
1 countries · 1 shipments · $237.36 · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$237.36
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Europe
1
Lithuania (100.0%)
$237.36
Top 1 Indian suppliers into Europe
1
LIFEON PHARMACEUTICALS
$237.36
Top 0 Europe importers
Top 1 dosage forms
1
Tablet
$237.36
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $237.36 | $237.36 |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — LIFEON PHARMACEUTICALS · 1 shipments · $237.36 | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Lithuania | Tablet | 50 | NOS | $4.75 | $237.36 | MUMBAI AIR (SAHAR) | VILNIUS | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
6 countries · 9 shipments · $174K · 4 Indian suppliers · 5 buyers
SHIPMENTS
9
USD
$174K
COUNTRIES
6
SUPPLIERS
4
BUYERS
5
HHI
5,085
concentrated
Top 6 destination countries in Americas
1
Guyana (56.7%)
$99K
2
United States (33.1%)
$58K
3
Colombia (6.4%)
$11K
4
Chile (1.8%)
$3K
5
Venezuela (1.7%)
$3K
6
Ecuador (0.3%)
$555.37
Top 4 Indian suppliers into Americas
1
MACLEODS PHARMACEUTICALS LTD
$110K
2
ALKEM LABORATORIES LTD
$58K
3
LUPIN LTD
$3K
4
MICRO LABS LTD
$3K
Top 5 Americas importers
1
NEW GPC INC · Guyana
$99K
2
ASCEND LABORATORIES LLC · United States
$58K
3
MINISTERIO DE SA · Ecuador
$12K
4
CENTRAL DE ABASTECIMIENTO · Chile
$3K
5
UNDP IN VENEZUELA CLAUDIA GONZALEZ · Venezuela
$3K
Top 1 dosage forms
1
Tablet
$174K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $3K | $3K |
| Nov | 7 | $160K | $23K |
| Dec | 1 | $11K | $11K |
Shipment register · 9 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MACLEODS PHARMACEUTICALS LTD · 3 shipments · $110K | |||||||||||
| 1 | Nov 2025 | NEW GPC INC | Guyana | Tablet | 54.0K | NOS | $0.913 | $49K | DELHI AIR | GEORGETOWN | AIR |
| 2 | Nov 2025 | NEW GPC INC | Guyana | Tablet | 54.0K | NOS | $0.913 | $49K | DELHI AIR | GEORGETOWN | AIR |
| 3 | Dec 2025 | MINISTERIO DE SA | Colombia | Tablet | 80.4K | NOS | $0.138 | $11K | DELHI AIR | BOGOTA | AIR |
| SUPPLIER #2 — ALKEM LABORATORIES LTD · 1 shipments · $58K | |||||||||||
| 4 | Nov 2025 | ASCEND LABORATORIES LLC | United States | Tablet | 9.5K | NOS | $6.09 | $58K | DELHI AIR | WASHINGTON, DULLES I | AIR |
| SUPPLIER #3 — LUPIN LTD · 4 shipments · $3K | |||||||||||
| 5 | Nov 2025 | UNDP IN VENEZUELA CLAUDIA GONZALEZ | Venezuela | Tablet | 938 | NOS | $1.02 | $956.25 | MUMBAI AIR (SAHAR) | CARACAS | AIR |
| 6 | Nov 2025 | UNDP IN VENEZUELA CLAUDIA GONZALEZ | Venezuela | Tablet | 938 | NOS | $1.02 | $956.25 | MUMBAI AIR (SAHAR) | CARACAS | AIR |
| 7 | Nov 2025 | UNDP IN VENEZUELA CLAUDIA GONZALEZ | Venezuela | Tablet | 938 | NOS | $1.02 | $956.25 | MUMBAI AIR (SAHAR) | CARACAS | AIR |
| 8 | Nov 2025 | MINISTERIO DE SA | Ecuador | Tablet | 400 | NOS | $1.39 | $555.37 | MUMBAI AIR (SAHAR) | QUITO | AIR |
| SUPPLIER #4 — MICRO LABS LTD · 1 shipments · $3K | |||||||||||
| 9 | Oct 2025 | CENTRAL DE ABASTECIMIENTO | Chile | Tablet | 1.6K | PCS | $2.01 | $3K | BANGALORE AIR | SANTIAGO DE CHILE - | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $13.69 · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$13.69
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Australia (100.0%)
$13.69
Top 1 Indian suppliers into Oceania
1
ZYPHARS PHARMACEUTICS PVT LTD
$13.69
Top 1 Oceania importers
1
TO THE CONSIGNEE · Australia
$13.69
Top 1 dosage forms
1
Tablet
$13.69
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $13.69 | $13.69 |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ZYPHARS PHARMACEUTICS PVT LTD · 1 shipments · $13.69 | |||||||||||
| 1 | Dec 2025 | TO THE CONSIGNEE | Australia | Tablet | 7 | NOS | $1.96 | $13.69 | MUMBAI AIR (SAHAR) | MELBOURNE | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 19 Indian isoniazid exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped isoniazid in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD | VILLAGE DUKHERI PO MOHRA | 25 | $1.79M | Tablet, Dispersible Tablet | Africa, Asia |
| 2 | LUPIN LTD | MUMBAI | 22 | $830K | Tablet | Africa, Americas |
| 3 | MICRO LABS LTD | HOSUR | 13 | $107K | Tablet | Africa, Americas |
| 4 | ALKEM LABORATORIES LTD | VILLAGE-THANA | 1 | $58K | Tablet | Americas |
| 5 | BIOMATRIX HEALTHCARE PVT LTD | AHMADABAD | 1 | $24K | Tablet | Africa |
| 6 | SAMRUDH PHARMACEUTICALS PVT LTD | BOISAR | 1 | $10K | Injection | Asia |
| 7 | SWETA DISTRIBUTORS PVT LTD | THANE | 2 | $2K | Tablet | Asia |
| 8 | WORLD HEALTH ORGANIZATION | 1 | $2K | Tablet | Asia | |
| 9 | HINDAZ.CORP | THANE WEST | 4 | $2K | Tablet | Asia |
| 10 | VATS INDUSTRIES PVT LTD | NEW DELHI | 5 | $870.31 | Tablet | Asia |
| 11 | PAXTER LIFESCIENCES | ADALAJ | 1 | $378.58 | Dispersible Tablet | Africa |
| 12 | SVIZERA LABS PVT LTD | NAVI MUMBAI | 1 | $268.35 | Tablet | Asia |
| 13 | LIFEON PHARMACEUTICALS | SURAT | 1 | $237.36 | Tablet | Europe |
| 14 | NILA PHARMACEUTICALS | SOUTH SOORANKUDY | 1 | $143.31 | Tablet | Asia |
| 15 | WORLDWIDE AYURHUB PVT LTD | KOCHI | 1 | $119.04 | Tablet | Asia |
| 16 | ZYPHARS PHARMACEUTICS PVT LTD | PUNE | 1 | $13.69 | Tablet | Oceania |
| 17 | RUTVA MEDICARE | SURAT | 1 | $3.06 | Tablet | Africa |
| 18 | MOVID IMPEX | MUMBAI | 2 | $1.14 | Tablet | Asia |
| 19 | BARAKAH BIOHEALTH LLP | Tiruppur | 2 | $0.303 | Tablet | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 36 global isoniazid importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian isoniazid in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | MINISTRY OF HEALTH & CHIL | Zimbabwe | 4 | $712K | MACLEODS PHARMACEUTI… | Tablet |
| 2 | PS -MOHCC - DPS (C) | Mozambique | 2 | $671K | MACLEODS PHARMACEUTI… | Tablet |
| 3 | XEON LOGISTICS | South Africa | 10 | $669K | LUPIN LTD | Tablet |
| 4 | UPD LEA GLEN, PHARMA DYNAMICS | South Africa | 5 | $155K | LUPIN LTD | Tablet |
| 5 | NEW GPC INC | Guyana | 2 | $99K | MACLEODS PHARMACEUTI… | Tablet |
| 6 | MACLEODS PHARMACEUTICALS SA | South Africa | 1 | $92K | MACLEODS PHARMACEUTI… | Tablet |
| 7 | PROGRAMME NATIONAL CONTRE LA | Benin | 1 | $84K | MACLEODS PHARMACEUTI… | Dispersible Tablet |
| 8 | UNOPS ARHC - .NO. 12(O)PYI THU LANE | Myanmar | 1 | $75K | MACLEODS PHARMACEUTI… | Dispersible Tablet |
| 9 | ASCEND LABORATORIES LLC | United States | 1 | $58K | ALKEM LABORATORIES LTD | Tablet |
| 10 | UNDP OFFICE IN SOUTH SUDAN | Kenya | 1 | $55K | MICRO LABS LTD | Tablet |
| 11 | AMERICAN EMBASSY (USAID) | Nepal | 2 | $26K | MACLEODS PHARMACEUTI… | Tablet |
| 12 | UNIQUE PHARMA | DR Congo | 1 | $24K | BIOMATRIX HEALTHCARE… | Tablet |
| 13 | UNDP/GLOBAL FUND PROJECT | Angola | 1 | $24K | MICRO LABS LTD | Tablet |
| 14 | NATIONAL EMERGENCY RESPONSE COUNCIL | Eswatini | 3 | $19K | MACLEODS PHARMACEUTI… | Tablet |
| 15 | PHARMACIE CENTRALE DES HOPITAUX | Algeria | 4 | $12K | MICRO LABS LTD | Tablet |
| 16 | MINISTERIO DE SA | Ecuador | 2 | $12K | MACLEODS PHARMACEUTI… | Tablet |
| 17 | CAMEL INTERNATIONAL IM-EXPORT CO LT | Vietnam | 1 | $10K | SAMRUDH PHARMACEUTIC… | Injection |
| 18 | CENTRAL DE ABASTECIMIENTO | Chile | 1 | $3K | MICRO LABS LTD | Tablet |
| 19 | UNDP IN VENEZUELA CLAUDIA GONZALEZ | Venezuela | 3 | $3K | LUPIN LTD | Tablet |
| 20 | HEALTHDECK DRUG STORE LLC | United Arab Emirates | 2 | $2K | SWETA DISTRIBUTORS P… | Tablet |
| 21 | WORLD HEALTH ORGANIZATION | Sri Lanka | 1 | $2K | WORLD HEALTH ORGANIZ… | Tablet |
| 22 | SIFAT PHARMA LLC | Tajikistan | 4 | $2K | HINDAZ.CORP | Tablet |
| 23 | UNOPS | Myanmar | 1 | $2K | LUPIN LTD | Tablet |
| 24 | INTERNATIONAL ORGANIZATION FOR MIGR | Yemen | 3 | $1K | LUPIN LTD | Tablet |
| 25 | MEDICAL ACCESS UGANDA LTD | Uganda | 1 | $682.94 | MICRO LABS LTD | Tablet |
| 26 | ATLAS TRADING COMPANY | Iraq | 3 | $642.78 | VATS INDUSTRIES PVT … | Tablet |
| 27 | M.S. TERMINAL CO LTD | Thailand | 1 | $492.89 | MACLEODS PHARMACEUTI… | Tablet |
| 28 | PHARMAPROM | Morocco | 1 | $378.58 | PAXTER LIFESCIENCES | Dispersible Tablet |
| 29 | CENAT (NATIONAL CENTER FOR | Cambodia | 2 | $292.35 | MACLEODS PHARMACEUTI… | Tablet |
| 30 | SEKRETARIAT DITJEN PENCEGAHAN DAN | Indonesia | 1 | $268.35 | SVIZERA LABS PVT LTD | Tablet |
| 31 | INTERNATIONAL ORGANIZATION FOR | Yemen | 4 | $247.20 | MACLEODS PHARMACEUTI… | Tablet |
| 32 | NATIONAL MEDICAL STORE | Sri Lanka | 1 | $143.31 | NILA PHARMACEUTICALS | Tablet |
| 33 | THE HEALINGS PLACE NATURAL HERBS | United Arab Emirates | 1 | $119.04 | WORLDWIDE AYURHUB PV… | Tablet |
| 34 | FEDERALMINISTRYOFHEALTH(FMOH) | Sudan | 1 | $27.55 | MICRO LABS LTD | Tablet |
| 35 | TO THE CONSIGNEE | Australia | 1 | $13.69 | ZYPHARS PHARMACEUTIC… | Tablet |
| 36 | EMIRATES POST GROUP | United Arab Emirates | 2 | $1.14 | MOVID IMPEX | Tablet |
This report covers 86 2025-Q4 Isoniazid shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/isoniazid
Talk to our trade analyst
Need a custom isoniazid report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/isoniazid
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Isoniazid product page
Live data, supplier directory, price trends, and trade route analysis